文献速递脑血管病神经重症与神经感染

急性大动脉缺血性卒中基线影像评估中MRI与CT的比较:SWIFT-DIRECT试验的子分析

MRI vs CT for Baseline Imaging Evaluation in Acute Large Artery Ischemic Stroke: A Subanalysis of the SWIFT-DIRECT Trial.
PubMed 文献 · Neurology · 2023-12-14

该研究为SWIFT-DIRECT试验的事后分析,纳入405例前循环大血管闭塞且符合静脉溶栓条件的急性缺血性卒中患者,比较基线MRI/MRA与CT/CTA对治疗效应的影响及与结局的关联。未发现影像模态与取栓联合或不联合静脉溶栓疗效之间存在交互作用;MRI/MRA与约20分钟的工作流程延迟相关,但90天功能独立 odds 更高(aOR 1.65,95%CI 1.07-2.56),死亡率相似(aOR 0.73,95%CI 0.36-1.47)。

要点

  • 基线MRI/MRA与CT/CTA相比,未显示对取栓联合或不联合静脉溶栓的治疗效应存在异质性。
  • MRI/MRA组的工作流程延迟约20分钟,但90天功能独立 odds 更高(aOR 1.65,95%CI 1.07-2.56)。
  • MRI/MRA组与CT/CTA组的死亡率相似(aOR 0.73,95%CI 0.36-1.47)。

核心结论

  • 该事后分析未提示不同影像模态的大动脉卒中患者中,静脉溶栓联合取栓与单纯取栓之间存在治疗效应异质性。
  • 尽管存在显著的工作流程延迟,无证据表明基线MRI/MRA后90天功能结局较CT/CTA更差。

研究设计与样本

  • SWIFT-DIRECT试验的事后分析,该试验研究发病4.5小时内符合静脉溶栓条件的急性前循环大血管闭塞性卒中患者中,单纯取栓对比静脉溶栓联合取栓的非劣效性。
  • 本亚组纳入408例中的405例患者;200例(49.4%)接受MRI/MRA,205例(50.6%)接受CT/CTA。
  • 主要分析检验基线影像模态与急性治疗(取栓 vs 静脉溶栓联合取栓)对临床和安全结局及操作指标的交互作用。
  • 次要分析使用回归模型校正年龄、性别、基线NIHSS、闭塞部位和ASPECTS,检验影像模态与结局的关联。
  • 影像模态由治疗医师酌情选择,通常反映中心特定标准流程。

主要发现

  • MRI/MRA组基线NIHSS评分低于CT/CTA组(16 [IQR 12-20] vs 18 [IQR 14-20],p=0.012),ASPECTS亦较低(8 [IQR 6-9] vs 8 [IQR 7-9],p=0.021)。
  • 主要分析未发现基线影像模态与静脉溶栓联合取栓对比单纯取栓的治疗效应之间存在交互作用的证据。
  • 次要分析中,MRI/MRA与工作流程延迟约20分钟相关,并与90天功能独立 odds 更高相关(aOR 1.65,95%CI 1.07-2.56)。
  • MRI/MRA与CT/CTA的死亡率相似(aOR 0.73,95%CI 0.36-1.47)。

关键数值与推荐

  • 主要分析未发现影像模态与治疗效应交互作用的证据。
  • MRI/MRA对比CT/CTA:90天功能独立 aOR 1.65(95%CI 1.07-2.56),死亡率 aOR 0.73(95%CI 0.36-1.47)。
  • MRI/MRA组基线NIHSS 16(IQR 12-20)vs CT/CTA组18(IQR 14-20),p=0.012。
  • MRI/MRA组基线ASPECTS 8(IQR 6-9)vs CT/CTA组8(IQR 7-9),p=0.021。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Whether MRI or CT is preferable for the evaluation of patients with suspected stroke remains a matter of debate, given that the imaging modality acquired at baseline may be a relevant determinant of workflow delays and outcomes with it, in patients with stroke undergoing acute reperfusion therapies. METHODS: In this post hoc analysis of the SWIFT-DIRECT trial that investigated noninferiority of thrombectomy alone vs IV thrombolysis (IVT) + thrombectomy in patients with an acute ischemic anterior circulation large vessel occlusive stroke eligible to receive IVT within 4.5 hours after last seen well, we tested for a potential interaction between baseline imaging modality (MRI/MR-angiography [MRA] vs CT/CT-angiography [CTA]) and the effect of acute treatment (thrombectomy vs IVT + thrombectomy) on clinical and safety outcomes and procedural metrics (primary analysis). Moreover, we examined the association between baseline imaging modality and these outcomes using regression models adjusted for age, sex, baseline NIH Stroke Scale (NIHSS), occlusion location, and Alberta Stroke Program Early CT Score (ASPECTS) (secondary analysis). Endpoints included workflow times, the modified Rankin scale (mRS) score at 90 days, the rate of successful reperfusion, the odds for early neurologic deterioration within 24 hours, and the risk of symptomatic intracranial hemorrhage. The imaging modality acquired was chosen at the discretion of the treating physicians and commonly reflects center-specific standard procedures. RESULTS: Four hundred five of 408 patients enrolled in the SWIFT-DIRECT trial were included in this substudy. Two hundred (49.4%) patients underwent MRI/MRA, and 205 (50.6%) underwent CT/CTA. Patients with MRI/MRA had lower NIHSS scores (16 [interquartile range (IQR) 12-20] vs 18 [IQR 14-20], p = 0.012) and lower ASPECTS (8 [IQR 6-9] vs 8 [IQR 7-9], p = 0.021) compared with those with CT/CTA. In terms of the primary analysis, we found no evidence for an interaction between baseline imaging modality and the effect of IVT + thrombectomy vs thrombectomy alone. Regarding the secondary analysis, MRI/MRA acquisition was associated with workflow delays of approximately 20 minutes, higher odds of functional independence at 90 days (adjusted odds ratio [aOR] 1.65, 95% CI 1.07-2.56), and similar mortality rates (aOR 0.73, 95% CI 0.36-1.47) compared with CT/CTA. DISCUSSION: This post hoc analysis does not suggest treatment effect heterogeneity of IVT + thrombectomy vs thrombectomy alone in large artery stroke patients with different imaging modalities. There was no evidence that functional outcome at 90 days was less favorable following MRI/MRA at baseline compared with CT/CTA, despite significant workflow delays. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov Identifier: NCT03192332.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Fladt J, Kaesmacher J, Meinel TR, et al. MRI vs CT for Baseline Imaging Evaluation in Acute Large Artery Ischemic Stroke: A Subanalysis of the SWIFT-DIRECT Trial. Neurology. 2023. PMID: 38165324. doi:10.1212/WNL.0000000000207922

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。